Suppr超能文献

白细胞介素-3调节髓系定向白血病细胞系中LYN蛋白酪氨酸激酶的活性。

Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines.

作者信息

Torigoe T, O'Connor R, Santoli D, Reed J C

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.

出版信息

Blood. 1992 Aug 1;80(3):617-24.

PMID:1638019
Abstract

The lymphokine interleukin-3 (IL-3) promotes the growth and survival of immature hematopoietic cells. Previous studies have shown that IL-3 induces rapid increases in protein-tyrosine kinase (PTK) activity in IL-3--dependent cells. Unlike some other hematopoietic growth factor receptors (eg, c-fms and c-kit), however, the known subunits of the IL-3 receptor (IL-3R) lack intrinsic kinase activity. Recently, it was reported that the IL-2R (whose p75 beta-subunit shares sequence homology with a known murine IL-3R subunit and a common beta-subunit of the human IL-3R and granulocyte-macrophage colony-stimulating factor [GM-CSF] receptors) can physically associate with and regulate the activity of the SRC-family PTK, p56-LCK. Because most IL-3--dependent cells contain p53/56-LYN, but not p56-LCK, we explored the effects of IL-3 on the activities of LYN and other SRC-like PTKs in two human leukemic cell lines, AML-193 and TALL-101, which are phenotypically myeloid, and whose in vitro growth is dependent on IL-3. These cells expressed four of the eight known SRC-family proto-oncogenes: lyn, fyn, yes, and hck. When these factor-dependent leukemic cell lines were deprived of lymphokine to achieve cellular quiescence and then restimulated with IL-3, rapid increases (detectable within 1 minute and maximal by 10 minutes) were observed in the activity of the p53/56-LYN kinase, as assessed by in vitro kinase assays. In contrast, no alteration in the activities of other SRC-family PTKs present in these cells was detected after restimulation with IL-3 under the same conditions. This effect of IL-3 reflected an increase in the specific activity of the LYN kinase, because levels of the 53-Kd and 56-Kd LYN proteins were unaltered by IL-3 stimulation, as assessed by immunoblotting. Furthermore, the magnitude of these inducible increases in LYN kinase activity was dependent on the concentration of IL-3, and correlated with IL-3--induced proliferation. The IL-3--induced upregulation of LYN kinase activity may be mediated by the 120-Kd common subunit of the human IL-3 and GM-CSF receptors, because GM-CSF also stimulated marked increases in the activity of the LYN kinase, whereas granulocyte-CSF (G-CSF) did not, despite inducing cellular proliferation. These observations provide the first example of an IL-3--regulable PTK, and strongly suggest that the p53/56-LYN kinase participates in early IL-3--initiated signalling events, at least in some human leukemic cell lines.

摘要

淋巴因子白细胞介素-3(IL-3)可促进未成熟造血细胞的生长和存活。以往研究表明,IL-3可使IL-3依赖细胞中的蛋白酪氨酸激酶(PTK)活性迅速升高。然而,与其他一些造血生长因子受体(如c-fms和c-kit)不同,IL-3受体(IL-3R)的已知亚基缺乏内在激酶活性。最近有报道称,IL-2R(其p75β亚基与已知的小鼠IL-3R亚基以及人IL-3R和粒细胞-巨噬细胞集落刺激因子[GM-CSF]受体的共同β亚基具有序列同源性)可与SRC家族PTK p56-LCK发生物理结合并调节其活性。由于大多数IL-3依赖细胞含有p53/56-LYN,但不含p56-LCK,我们研究了IL-3对两种人白血病细胞系AML-193和TALL-101中LYN及其他SRC样PTK活性的影响,这两种细胞系在表型上为髓样,其体外生长依赖于IL-3。这些细胞表达了8种已知SRC家族原癌基因中的4种:lyn、fyn、yes和hck。当这些因子依赖的白血病细胞系被剥夺淋巴因子以实现细胞静止,然后用IL-3重新刺激时,通过体外激酶测定评估,观察到p53/56-LYN激酶活性迅速升高(1分钟内可检测到,10分钟时达到最大值)。相比之下,在相同条件下用IL-3重新刺激后,未检测到这些细胞中存在的其他SRC家族PTK活性有改变。IL-3的这种作用反映了LYN激酶比活性的增加,因为通过免疫印迹评估,53-Kd和56-Kd LYN蛋白的水平未因IL-3刺激而改变。此外,LYN激酶活性的这些诱导性增加的幅度取决于IL-3的浓度,并与IL-3诱导的增殖相关。IL-3诱导的LYN激酶活性上调可能由人IL-3和GM-CSF受体的120-Kd共同亚基介导,因为GM-CSF也刺激LYN激酶活性显著增加,而粒细胞集落刺激因子(G-CSF)尽管诱导细胞增殖,但却没有这种作用。这些观察结果提供了第一个IL-3可调节PTK的例子,并强烈表明p53/56-LYN激酶至少在一些人白血病细胞系中参与了早期IL-3启动的信号事件。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验